Results 151 to 160 of about 84,919 (278)

Biomarkers Associated with Immune Checkpoint, N6-Methyladenosine, and Ferroptosis in Patients with Restenosis

open access: yesJournal of Inflammation Research, 2023
Xiao Tong, Xinyi Zhao, Xuan Dang, Yan Kou, Junjie Kou Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, People’s Republic of ...
Tong X, Zhao X, Dang X, Kou Y, Kou J
doaj  

Efficacy of Drug-Eluting Stents for Treating In-Stent Restenosis of Drug-Eluting Stents (from the Korean DES ISR Multicenter Registry Study [KISS]) [PDF]

open access: bronze, 2011
Young‐Guk Ko   +12 more
openalex   +1 more source

Restenosis [PDF]

open access: yesCirculation, 2003
openaire   +2 more sources

Safety, Efficacy and Clinical Outcome of Direct Stent Implantation [PDF]

open access: yesJournal of Kerman University of Medical Sciences, 2004
Conventional methods of stenting require predilatation, which potentially increase vessel wall injury and cost of the procedure. In this study, the safety and efficacy of direct AVE-S7 (Medtronic-USA) stent placement were evaluated in 100 patients ...
B Sarvar-Azimzadeh, Sh Narooi
doaj  

Association of Circulating IgE and CML Levels with In-Stent Restenosis in Type 2 Diabetic Patients with Stable Coronary Artery Disease [PDF]

open access: gold, 2022
Jingmeng Liu   +12 more
openalex   +1 more source

Heyde Syndrome: A Literature Review

open access: yesHealth Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background and Aims Heyde syndrome, a triad of anemia from gastrointestinal (GI) bleeding, aortic valve stenosis, and acquired von Willebrand syndrome, primarily affects individuals over 65. Management requires a multidisciplinary approach, including medical therapy, endoscopic intervention, and valve replacement.
Yashika Gupta   +12 more
wiley   +1 more source

Progress in RNA‐Targeted Therapeutics for Human Diseases

open access: yesMedComm, Volume 7, Issue 2, February 2026.
RNA‐targeted therapies are revolutionizing molecular medicine by transitioning from a “protein‐centric” focus to an “RNA‐regulatory network” approach. Leveraging RNA's diverse roles in gene regulation, signaling, and epigenetic modifications, advanced platforms such as ASOs, siRNA, miRNA, mRNA, aptamers, shRNA, and CRISPR/Cas systems are enabling ...
Wangzheqi Zhang   +10 more
wiley   +1 more source

Application of underdamped Langevin dynamics simulations for the study of diffusion from a drug-eluting stent

open access: yes, 2018
We use a one-dimensional two layer model with a semi-permeable membrane to study the diffusion of a therapeutic drug delivered from a drug-eluting stent (DES).
Farago, Oded, Regev, Shaked
core   +1 more source

Home - About - Disclaimer - Privacy